Selected article for: "cell line and monoclonal antibody"

Author: Focosi, Daniele; Maggi, Fabrizio; Mazzetti, Paola; Pistello, Mauro
Title: Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
  • Cord-id: xy013ecy
  • Document date: 2020_9_21
  • ID: xy013ecy
    Snippet: Viral neutralization tests (VNTs) have long been considered old‐fashioned tricks in the armamentarium of fundamental virology, with laboratory implementation for a limited array of viruses only. Nevertheless, they represent the most reliable surrogate of potency for passive immunotherapies, such as monoclonal or polyclonal antibody therapy. The recent interest around therapy with convalescent plasma or monoclonal antibodies for the Covid‐19 pandemic has paralleled the revival of VNTs. We rev
    Document: Viral neutralization tests (VNTs) have long been considered old‐fashioned tricks in the armamentarium of fundamental virology, with laboratory implementation for a limited array of viruses only. Nevertheless, they represent the most reliable surrogate of potency for passive immunotherapies, such as monoclonal or polyclonal antibody therapy. The recent interest around therapy with convalescent plasma or monoclonal antibodies for the Covid‐19 pandemic has paralleled the revival of VNTs. We review here the available methods by dissecting variations for each fundamental component of the VNT (i.e., virus type and dose, replication‐competent cell line, serum, and detection system).

    Search related documents:
    Co phrase search for related documents
    • acute phase and luciferase reporter: 1